ABBOTINDIA

Abbott India Limited

Abbott India Limited (ABBOTINDIA) financial statements and selected valuation metrics through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

abbott.co.in(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹26170.00
Market cap
55,611 Cr
Stock P/E
34.4
P/B
11.65
Dividend yield
1.8%
ROE (FY26)
32.5%
ROCE (FY26)
44.1%
Operating margin (FY26)
26.2%
Debt / equity (FY26)
0.00
OCF / EBITDA (FY26)
69.7%
OCF / EBITDA (3Y)
70.3%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

Company snapshot

14thBy market cap

Ranked among 119 companies in Pharmaceuticals.

What we see

Positives
  • ✓Net margin of 22.4% — the business keeps a healthy share of every rupee it earns.
4 more signals from the filings.Sign in free to see them all

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Standalone only

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales1,494 Cr1,437 Cr1,439 Cr1,558 Cr1,633 Cr1,614 Cr1,605 Cr1,738 Cr1,757 Cr1,724 Cr1,710 Cr1,814 Cr
Operating expenses (approx.)1,113 Cr1,049 Cr1,109 Cr1,167 Cr1,194 Cr1,178 Cr1,176 Cr1,293 Cr1,255 Cr1,261 Cr1,229 Cr1,291 Cr
EBITDA381 Cr388 Cr330 Cr391 Cr439 Cr436 Cr429 Cr446 Cr502 Cr463 Cr481 Cr523 Cr
OPM %25.5%27.0%22.9%25.1%26.9%27.0%26.7%25.6%28.6%26.9%28.1%28.8%
Other income56 Cr56 Cr81 Cr67 Cr60 Cr72 Cr76 Cr73 Cr70 Cr70 Cr76 Cr75 Cr
Interest3 Cr3 Cr3 Cr3 Cr3 Cr2 Cr4 Cr6 Cr8 Cr5 Cr6 Cr6 Cr
Depreciation18 Cr18 Cr18 Cr18 Cr18 Cr18 Cr18 Cr19 Cr19 Cr19 Cr19 Cr20 Cr
Profit before tax415 Cr422 Cr390 Cr437 Cr479 Cr488 Cr483 Cr493 Cr546 Cr509 Cr531 Cr572 Cr
Tax %24.7%26.3%26.3%25.0%25.2%26.0%24.0%25.8%23.9%26.1%25.7%25.1%
Net profit313 Cr311 Cr287 Cr328 Cr359 Cr361 Cr367 Cr366 Cr415 Cr376 Cr395 Cr429 Cr
EPS (₹)₹147.27₹146.34₹565.28₹154.36₹168.76₹169.78₹172.72₹172.17₹195.42₹176.92₹185.85₹201.66

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales2,939 Cr3,307 Cr3,679 Cr4,093 Cr4,310 Cr4,919 Cr5,349 Cr5,849 Cr6,409 Cr6,929 CrSign in free for the trailing twelve months
Operating expenses (approx.)2,541 Cr2,783 Cr3,074 Cr3,337 Cr3,389 Cr3,832 Cr4,143 Cr4,396 Cr4,715 Cr5,037 CrSign in free for the trailing twelve months
EBITDA397 Cr525 Cr605 Cr756 Cr921 Cr1,088 Cr1,206 Cr1,453 Cr1,695 Cr1,892 CrSign in free for the trailing twelve months
OPM %13.5%15.9%16.4%18.5%21.4%22.1%22.5%24.8%26.4%27.3%Sign in free for the trailing twelve months
Other income58 Cr117 Cr113 Cr114 Cr81 Cr77 Cr154 Cr248 Cr276 Cr288 CrSign in free for the trailing twelve months
Interest2 Cr4 Cr2 Cr9 Cr18 Cr19 Cr16 Cr12 Cr11 Cr25 CrSign in free for the trailing twelve months
Depreciation16 Cr16 Cr17 Cr60 Cr58 Cr66 Cr70 Cr71 Cr72 Cr76 CrSign in free for the trailing twelve months
Profit before tax436 Cr621 Cr699 Cr803 Cr926 Cr1,080 Cr1,274 Cr1,618 Cr1,887 Cr2,079 CrSign in free for the trailing twelve months
Tax %36.6%35.4%35.6%26.1%25.4%26.0%25.5%25.7%25.0%25.4%Sign in free for the trailing twelve months
Net profit277 Cr401 Cr450 Cr593 Cr691 Cr799 Cr949 Cr1,201 Cr1,414 Cr1,552 CrSign in free for the trailing twelve months
EPS (₹)₹130.19₹188.81₹211.93₹279.04₹325.04₹375.86₹446.78₹446.78₹665.62₹730.36Sign in free for the trailing twelve months
Dividend payout %————76.9%73.2%61.5%57.5%61.6%65.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital21 Cr21 Cr21 Cr21 Cr21 Cr21 Cr21 Cr21 Cr21 Cr21 Cr
Reserves1,366 Cr1,672 Cr1,987 Cr2,410 Cr2,581 Cr2,799 Cr3,167 Cr3,678 Cr4,212 Cr4,753 Cr
Borrowings——————————
Other liabilities679 Cr723 Cr932 Cr1,115 Cr1,238 Cr1,404 Cr1,367 Cr1,495 Cr1,684 Cr1,728 Cr
Total liabilities2,066 Cr2,416 Cr2,941 Cr3,547 Cr3,840 Cr4,224 Cr4,556 Cr5,193 Cr5,917 Cr6,502 Cr
Fixed assets (net)108 Cr79 Cr103 Cr269 Cr250 Cr262 Cr229 Cr218 Cr330 Cr328 Cr
CWIP5 Cr2 Cr0.73 Cr2 Cr0.66 Cr0.66 Cr4 Cr10 Cr18 Cr6 Cr
Investments——0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr
Loans & advances——7 Cr6 Cr5 Cr0 Cr0 Cr0 Cr0 Cr0 Cr
Inventories501 Cr585 Cr607 Cr527 Cr718 Cr688 Cr649 Cr620 Cr882 Cr947 Cr
Trade receivables176 Cr263 Cr276 Cr318 Cr250 Cr288 Cr317 Cr319 Cr380 Cr362 Cr
Cash & bank202 Cr38 Cr137 Cr145 Cr218 Cr133 Cr240 Cr292 Cr561 Cr442 Cr
Other assets1,074 Cr1,449 Cr1,810 Cr2,280 Cr2,399 Cr2,852 Cr3,117 Cr3,735 Cr3,747 Cr4,418 Cr
Total assets2,066 Cr2,416 Cr2,941 Cr3,547 Cr3,840 Cr4,224 Cr4,556 Cr5,193 Cr5,917 Cr6,502 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity307 Cr153 Cr499 Cr626 Cr727 Cr948 Cr893 Cr1,213 Cr1,012 Cr1,319 Cr
Cash from investing-155 Cr-215 Cr-257 Cr-401 Cr-72 Cr-396 Cr-148 Cr-416 Cr182 Cr-371 Cr
Cash from financing-90 Cr-102 Cr-143 Cr-217 Cr-582 Cr-637 Cr-639 Cr-745 Cr-925 Cr-1,066 Cr
Net cash flow62 Cr-165 Cr99 Cr8 Cr73 Cr-86 Cr107 Cr52 Cr269 Cr-118 Cr
Free cash flow (OCF − Capex)286 Cr136 Cr487 Cr610 Cr703 Cr904 Cr859 Cr1,164 Cr959 Cr1,278 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %31.6%36.9%34.9%33.4%36.3%39.0%40.5%44.1%44.8%44.1%
ROE %19.9%23.7%22.4%24.4%26.5%28.3%29.8%32.5%33.4%32.5%
Debtor days22292728212122202219
Inventory days577720543426575505423400517562
Days payable547592594531611653581647620656
Cash conversion cycle52158-23-77-15-127-137-227-81-76
OCF / EBITDA %77.3%29.1%82.5%82.8%78.9%87.1%74.1%83.5%59.7%69.7%
OCF / EBITDA % (3 years)——62.8%67.8%81.1%83.2%79.9%81.5%71.6%70.3%
Debt / equity——0.000.000.000.000.000.000.000.00
Current ratio3.003.393.223.603.413.202.512.423.372.55
Net debt / EBITDA-0.51-0.07-0.23-0.19-0.24-0.12-0.20-0.20-0.33-0.23